Kura Oncology (KURA) Profit After Tax (2010 - 2026)
Kura Oncology (KURA) reported Profit After Tax of -$73.3 million for Q1 2026, down 27.69% year-over-year from -$101.4 million in Q1 2025, and up 9.46% on a QoQ basis from -$81.0 million in Q4 2025.
Kura Oncology (KURA) has 17 years of Profit After Tax data on file, last reported at -$73.3 million in Q1 2026.
- Quarterly Profit After Tax fell 27.69% year-over-year to -$73.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$294.6 million (down 61.95% YoY) and the FY2025 annual result came in at -$278.7 million, down 60.17% from the prior year.
- Profit After Tax rose to -$73.3 million in Q1 2026 per KURA's latest filing, from -$81.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$19.2 million in Q4 2024 and bottomed at -$81.0 million in Q4 2025.
- The 5-year median for Profit After Tax is -$42.8 million (2023), against an average of -$47.9 million.
- The widest annual swing landed in 2024, when Profit After Tax jumped 55.09%; it then sank 321.5% in 2025.
- Tracing KURA's Profit After Tax over 5 years: stood at -$33.1 million in 2022, then retreated by 29.21% to -$42.8 million in 2023, then jumped by 55.09% to -$19.2 million in 2024, then slumped by 321.5% to -$81.0 million in 2025, then rose by 9.46% to -$73.3 million in 2026.
- Per Business Quant, the three latest KURA Profit After Tax figures stand at -$73.3 million (Q1 2026), -$81.0 million (Q4 2025), and -$74.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -73.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.33 Mn |
| Dec 31, 2025 | -81.00 Mn |
| Sep 30, 2025 | -74.12 Mn |
| Jun 30, 2025 | -66.12 Mn |
| Mar 31, 2025 | -57.43 Mn |
| Dec 31, 2024 | -19.22 Mn |
| Sep 30, 2024 | -54.40 Mn |
| Jun 30, 2024 | -50.84 Mn |
| Mar 31, 2024 | -49.53 Mn |
| Dec 31, 2023 | -42.79 Mn |
| Sep 30, 2023 | -38.60 Mn |
| Jun 30, 2023 | -37.17 Mn |
| Mar 31, 2023 | -34.07 Mn |
| Dec 31, 2022 | -33.11 Mn |
| Sep 30, 2022 | -35.50 Mn |
| Jun 30, 2022 | -34.77 Mn |
| Mar 31, 2022 | -32.45 Mn |
| Dec 31, 2021 | -32.74 Mn |
| Sep 30, 2021 | -33.37 Mn |
| Jun 30, 2021 | -33.66 Mn |
| Mar 31, 2021 | -30.69 Mn |
| Dec 31, 2020 | -26.16 Mn |
| Sep 30, 2020 | -23.77 Mn |
| Jun 30, 2020 | -20.49 Mn |
| Mar 31, 2020 | -19.21 Mn |
| Dec 31, 2019 | -17.87 Mn |
| Sep 30, 2019 | -16.39 Mn |
| Jun 30, 2019 | -14.94 Mn |
| Mar 31, 2019 | -13.94 Mn |
| Dec 31, 2018 | -16.10 Mn |
| Sep 30, 2018 | -15.01 Mn |
| Jun 30, 2018 | -14.74 Mn |
| Mar 31, 2018 | -14.60 Mn |
| Dec 31, 2017 | -10.75 Mn |
| Sep 30, 2017 | -9.33 Mn |
| Jun 30, 2017 | -7.82 Mn |
| Mar 31, 2017 | -7.53 Mn |
| Dec 31, 2016 | -7.35 Mn |
| Sep 30, 2016 | -6.93 Mn |
| Jun 30, 2016 | -6.66 Mn |
| Mar 31, 2016 | -6.63 Mn |
| Dec 31, 2015 | -6.47 Mn |
| Sep 30, 2015 | -6.09 Mn |
| Jun 30, 2015 | -5.59 Mn |
| Mar 31, 2015 | -4.48 Mn |
| Dec 31, 2014 | -3.67 Mn |
| Sep 30, 2014 | -66,000.00 |
| Jun 30, 2014 | -6,887.00 |
| Mar 31, 2014 | -5,766.00 |
| Dec 31, 2013 | -9,750.00 |
| Sep 30, 2013 | -6,139.00 |
| Jun 30, 2013 | -6,749.00 |
| Mar 31, 2013 | -5,973.00 |
| Dec 31, 2012 | -9,662.00 |
| Sep 30, 2012 | -6,013.00 |
| Jun 30, 2012 | -6,268.00 |
| Mar 31, 2012 | -5,372.00 |
| Dec 31, 2011 | -8,884.00 |
| Sep 30, 2011 | -6,267.00 |
| Jun 30, 2011 | -6,735.00 |
| Mar 31, 2011 | -5,154.00 |
| Dec 31, 2010 | -7,746.00 |
| Sep 30, 2010 | -4,767.00 |